SEARCH

SEARCH BY CITATION

References

  • 1
    Andre, C., Hampe, A., Lachaume, P., Martin, E., Wang, X.P., Manus, V., Hu, W.X. & Galibert, F. (1997) Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics, 39, 216226.DOI: 10.1006/geno.1996.4482
  • 2
    Beghini, A., Larizza, L., Cairoli, R. & Morra, E. (1998) c-kit activating mutations and mast cell proliferation in human leukemia. (Letter). Blood, 92, 701702.
  • 3
    Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H. & Sultan, G. (1976) Proposals for the classification of the acute leukaemias. British Journal of Haematology, 33, 451458.
  • 4
    Besmer, P., Murphy, J.E., George, P.C., Qui, F., Bergold, P.J., Ledermann, L., Synder, H.W., Brodeur, D., Zuckermann, E.E. & Hardy, W.D. (1986) A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature, 320, 415421.
  • 5
    Blechman, J.M. & Yarden, Y. (1995) Structural aspects of receptor dimerization. c-Kit as an example. Annals of the New York Academy of Sciences, 766, 344362.
  • 6
    Bowen, D.T., Padua, R.A., Burnett, A.K., DeCastro, C.M. & Kaufman, R.E. (1993) Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots. Leukemia, 7, 18831885.
  • 7
    Broudy, V.C. (1997) Stem cell factor and hematopoiesis. Blood, 90, 13451364.
  • 8
    Carlberg, K. & Rohrschneider, L. (1994) The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor. Molecular Biology of the Cell, 5, 8195.
  • 9
    Cross, N.C.P., Hughes, T.P., Feng, L., O'Shea, L., Bungey, J., Marks, D.I., Ferrant, A., Martiat, P. & Goldman, J.M. (1993) Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. British Journal of Haematology, 84, 6774.
  • 10
    Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y., Matsuzawa, Y., Kitamura, Y. & Kanakura, Y. (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. Journal of Clinical Investigation, 92, 17361744.
  • 11
    Grimwade, D., Walker, H., Oliver, F., Wheatly, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A., on behalf of the Medical Research Council adult and children's leukaemia working parties (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood, 92, 23222333.
  • 12
    Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Tunio, G.M., Matsuzawa, Y., Kanakura, Y., Shinomura, Y. & Kitamura, Y. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 279, 577580.DOI: 10.1126/science.279.5350.577
  • 13
    Ikeda, H., Kanakura, Y., Tamaki, T., Kuriu, A., Kitayama, H., Ishikawa, J., Kanayama, Y., Yonzawa, T., Tarui, S. & Griffin, J. (1991) Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood, 78, 29622968.
  • 14
    Kanakura, Y., Ikeda, H., Kitayama, H., Sugahara, H. & Furitsu, T. (1993) Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. Leukemia and Lymphoma, 10, 3541.
  • 15
    Kimura, A., Nakata, Y., Katoh, O. & Hyodo, H. (1997) c-kit point mutation in patients with myeloproliferative disorders. Leukemia and Lymphoma, 25, 281287.
  • 16
    Kubota, T., Hikono, H., Sasaki, E. & Sakurai, M. (1994) Sequence of a bovine c-kit proto-oncogene cDNA. Gene, 141, 305306.DOI: 10.1016/0378-1119(94)90592-4
  • 17
    Longley, B.J., Tyrrell, L., Lu, S., Ma, Y., Langley, K., Ding, T., Duffy, T., Jacobs, P., Tang, L.H. & Modlin, I. (1996) Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genetics, 12, 312314.DOI: 10.1038/ng0396-312
  • 18
    Nagata, H., Worobec, A.S., Chad, K.O., Chowdhury, B.A., Tannenbaum, S., Suzuki, Y. & Metcalf, D.D. (1995) Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proceedings of the National Academy of Sciences of the United States of America, 92, 1056010564.
  • 19
    Paguette, R.L., Hsu, N.C. & Koeffler, H.P. (1996) Analysis of c-kit integrity in aplastic anemia. Blood Cells, Molecules and Diseases, 22, 159168.DOI: 10.1006/bcmd.1996.0023
  • 20
    Qui, F., Ray, P., Brown, K., Barker, P.E., Jhanwar, S., Ruddle, F.H. & Besmer, P. (1988) Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO Journal, 7, 10031011.
  • 21
    Reith, A.D. & Bernstein, A. (1991) Molecular biology of the W and Steel loci. Genes and Phenotypes (ed. by K. E. Davies and S. Tilghman), Vol. 3, p. 105. Cold Spring Harbor Laboratory, New York.
  • 22
    Riva, P. & Larizza, L. (1996) A novel potentially diagnostic polymorphism (4894 A/C) in exon 10 of the human c-kit proto-oncogene. Molecular and Cellular Probes, 10, 387388.DOI: 10.1006/mcpr.1996.0052
  • 23
    Rosnet, O., Schiff, C., Pébusque, M.-J., Marchetto, S., Tonnelle, C., Toiron, Y., Birg, F. & Birnbaum, D. (1993) Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood, 82, 11101119.
  • 24
    Sasaki, E., Okamura, H., Chikamune, T., Kanai, Y., Watanabe, M., Naito, M. & Sakurai, M. (1993) Cloning and expression of the chicken c-kit proto-oncogene. Gene, 128, 257261.DOI: 10.1016/0378-1119(93)90571-J
  • 25
    Spritz, R.A., Giebel, L.B. & Holmes, S.A. (1992) Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. American Journal of Human Genetics, 50, 261269.
  • 26
    Tanaka, S., Yanagisawa, N., Tojo, H., Kim Y., J., Tsujimura, T., Kitamura, Y., Sawasaki, T. & Tachi, C. (1997) Molecular cloning of cDNA encoding the c-kit receptor of Shiba goats and a novel alanine insertion specific to goats and sheep in the kinase insert region. Biochimica et Biophysica Acta, 1352, 151155.
  • 27
    Tsujimura, T., Furitsu, T., Morimoto, M., Isozaki, K., Nomura, S., Matsuzawa, Y., Kitamura, Y. & Kanakura, Y. (1994) Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood, 83, 26192626.
  • 28
    Tsujimura, T., Furitsu, T., Morimoto, M., Kanayama, Y., Nomura, S., Matsuzawa, Y., Kitamura, Y. & Kanakura, Y. (1995) Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumour mast cell line RBL-2H3. International Archives of Allergy and Immunology, 106, 377385.
  • 29
    Tsujimura, T., Hirota, S., Nomura, S., Niwa, Y., Yamazaki, M., Tono, T., Morii, E., Kim, H., Kondo, K., Nishimune, Y. & Kitamura, Y. (1991) Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. Blood, 78, 19421946.
  • 30
    Tsujimura, T., Morimoto, M., Hashimoto, K., Moriyama, Y., Kitayama, H., Matsuzawa, Y., Kitamura, Y. & Kanakura, Y. (1996) Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood, 87, 273283.
  • 31
    Ullrich, A. & Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203212.
  • 32
    Van Daalen Wetters, T., Hawkins, S.A., Roussel, M.F. & Sherr, C.J. (1992) Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. EMBO Journal, 11, 551557.
  • 33
    Wang, C., Curtis, J.E., Geissler, E.N., McCulloch, E.A. & Minden, M.D. (1989) The expression of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood, 78, 29622968.
  • 34
    Williams, I.J., Abuzenadah, A., Winship, P.R., Preston, F.E., Dolan, G., Wright, J., Peake, I.R. & Goodeve, A.C. (1998) Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thrombosis and Haemostasis, 79, 723726.
  • 35
    Yarden, Y., Kuang, W.J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T.J., Chen, E., Schessinger, J., Francke, U. & Ullrich, A. (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO Journal, 6, 33413351.
  • 36
    Yarden, Y. & Ullrich, A. (1988) Growth factor receptor tyrosine kinases. Annual Review of Biochemistry, 57, 443478.DOI: 10.1146/annurev.bi.57.070188.002303